LOCK-IN
LIVE

Serial Number

99835491

Owner

DNA TWOPOINTO INC.

Attorney

Benjamen E. Kern

Filing Date

May 20, 2026

Add to watchlist:

No watchlists yet
View on USPTO

LOCK-IN Trademark

Serial Number: 99835491

LOCK-IN is a trademark filed by DNA TWOPOINTO INC. on May 20, 2026. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

DNA TWOPOINTO INC. (16 trademarks)

37950 Central Court
Newark, CA 94560

Entity Type: 03

Trademark Details

Filing Date

May 20, 2026

Registration Date

Not Registered

Goods & Services

Medical and scientific research in the fields of human or animal monoclonal, bispecific, trimeric or other multispecific antibody formats to treat diseases; medical research services, namely, protein engineering in the fields of human monoclonal, bispecific, trimeric or other multispecific antibody formats to treat diseases; pharmaceutical product development in the fields of human monoclonal or trimeric antibodies to treat diseases; contract research services in the fields of human monoclonal, bispecific, trimeric or other multispecific antibody formats to treat diseases; consulting services in the field of biotechnology and genetic science; consulting services in the field of pharmaceutical research and development; scientific research consulting in the field of biotechnology and bioengineering; providing information on the subject of scientific research in the field of biochemistry and biotechnology; research and development of new products for others.

Biochemicals, namely, monoclonal, bispecific, and trimeric or other multispecific antibody formats, and derivatives thereof for in-vivo or in-vitro scientific research and development to treat diseases and for use in laboratories, diagnostics and analytics for scientific or research use.

Pharmaceutical preparations based on human or animal monoclonal, bispecific, trimeric or other multispecific antibody formats, and derivatives thereof for treating diseases, for use in related diagnostic or therapeutic use, and for use as medical diagnostic assays for testing of body fluids or tissues, for use in disease detection, including, cancers, inflammatory diseases, autoimmune diseases, infectious diseases and cardiovascular diseases.

Filing History

APPLICATION FILING RECEIPT MAILED
May 20, 2026 MAFR
NEW APPLICATION ENTERED
May 20, 2026 NWAP